Molecular evolution and emergence of avian gammacoronaviruses

Infection, Genetics and Evolution

Volumn 12, Issue 6, 2012, Pages 1305-1311

  Jackwood, Mark W ^a   Hall, David ^b   Handel, Andreas ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b NONE   (United States)

Author keywords

Coronavirus; Emergence; Evolution; Nidovirus; Virus diversity

Indexed keywords

GLYCOPROTEIN; INACTIVATED VACCINE; LIVE VACCINE; VIRUS PROTEIN;

AVIAN INFECTIOUS BRONCHITIS; AVIAN INFECTIOUS BRONCHITIS VIRUS; BIRD; CLINICAL FEATURE; CORONAVIRUS; CORONAVIRUS INFECTION; DISEASE TRANSMISSION; GAMMACORONAVIRUS; GENE MUTATION; GENETIC RECOMBINATION; GENETIC VARIABILITY; IMMUNE RESPONSE; MOLECULAR EVOLUTION; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; S1 GENE; SEROTYPE; UNTRANSLATED REGION; VIRUS GENE; VIRUS GENOME; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS STRAIN; VIRUS SURVIVAL; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANIMALS; BIRD DISEASES; BIRDS; COMMUNICABLE DISEASES, EMERGING; CORONAVIRUS INFECTIONS; EVOLUTION, MOLECULAR; INFECTIOUS BRONCHITIS VIRUS;

ANIMALIA; AVES; AVIAN INFECTIOUS BRONCHITIS VIRUS; CORONAVIRUS; GALLUS GALLUS; RNA VIRUSES;

EID: 84861942409     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2012.05.003     Document Type: Review

References (88)

1. Abrahams M.R., Anderson J.A., Giorgi E.E., Seoighe C., Mlisana K., Ping L.H., Athreya G.S., Treurnicht F.K., Keele B.F., Wood N., Salazar-Gonzalez J.F., Bhattacharya T., Chu H., Hoffman I., Galvin S., Mapanje C., Kazembe P., Thebus R., Fiscus S., Hide W., Cohen M.S., Karim S.A., Haynes B.F., Shaw G.M., Hahn B.H., Korber B.T., Swanstrom R., Williamson C. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J. Virol. 2009, 83:3556-3567.
2. Antia R., Regoes R.R., Koella J.C., Bergstrom C.T. The role of evolution in the emergence of infectious diseases. Nature 2003, 426:658-661.
3. Armesto M., Cavanagh D., Britton P. The replicase gene of avian coronavirus infectious bronchitis virus is a determinant of pathogenicity. PLoS One 2009, 4:e7384.
4. Barretto N., Jukneliene D., Ratia K., Chen Z., Mesecar A.D., Baker S.C. The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. J. Virol. 2005, 79:15189-15198.
5. Bouma A., Claassen I., Natih K., Klinkenberg D., Donnelly C.A., Koch G., van Boven M. Estimation of transmission parameters of H5N1 avian influenza virus in chickens. PLoS Pathog. 2009, 5:e1000281.
6. Brooks J.E., Rainer A.C., Parr R.L., Woolcock P., Hoerr F., Collisson E.W. Comparisons of envelope through 5B sequences of infectious bronchitis coronaviruses indicates recombination occurs in the envelope and membrane genes. Virus Res. 2004, 100:191-198.
7. Callison S.A., Jackwood M.W., Hilt D.A. Molecular characterization of infectious bronchitis virus isolates foreign to the United States and comparison with United States isolates. Avian Dis. 2001, 45:492-499.
8. Campos P.R., Wahl L.M. The effects of population bottlenecks on clonal interference, and the adaptation effective population size. Evolution 2009, 63:950-958.
9. Cavanagh D. Coronavirus avian infectious bronchitis virus. Vet. Res. 2007, 38:281-297.
10. Cavanagh D., Gelb J. Infectious bronchitis. Diseases of Poultry 2008, 117-135. Blackwell Publishing, Ames, Iowa, Ames, IA. 12th ed. Y.M. Saif (Ed.).
11. Cavanagh D., Mawditt K., Adzhar A., Gough R.E., Picault J.P., Naylor C.J., Haydon D., Shaw K., Britton P. Does IBV change slowly despite the capacity of the spike protein to vary greatly?. Adv. Exp. Med. Biol. 1998, 440:729-734.
12. Clementz M.A., Chen Z., Banach B.S., Wang Y., Sun L., Ratia K., Baez-Santos Y.M., Wang J., Takayama J., Ghosh A.K., Li K., Mesecar A.D., Baker S.C. Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. J. Virol. 2010, 84:4619-4629.
13. Clune J., Misevic D., Ofria C., Lenski R.E., Elena S.F., Sanjuan R. Natural selection fails to optimize mutation rates for long-term adaptation on rugged fitness landscapes. PLoS Comput. Biol. 2008, 4:e1000187.
14. Coffey L.L., Vasilakis N., Brault A.C., Powers A.M., Tripet F., Weaver S.C. Arbovirus evolution in vivo is constrained by host alternation. Proc. Natl. Acad. Sci. USA 2008, 105:6970-6975.
15. de Wit J.J., de Jong M.C., Pijpers A., Verheijden J.H. Transmission of infectious bronchitis virus within vaccinated and unvaccinated groups of chickens. Avian Pathol. 1998, 27:464-471.
16. Decaro N., Mari V., Campolo M., Lorusso A., Camero M., Elia G., Martella V., Cordioli P., Enjuanes L., Buonavoglia C. Recombinant canine coronaviruses related to transmissible gastroenteritis virus of swine are circulating in dogs. J. Virol. 2009, 83:1532-1537.
17. Eckerle L.D., Becker M.M., Halpin R.A., Li K., Venter E., Lu X., Scherbakova S., Graham R.L., Baric R.S., Stockwell T.B., Spiro D.J., Denison M.R. Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. PLoS Pathog. 2010, 6:e1000896.
18. Eckerle L.D., Lu X., Sperry S.M., Choi L., Denison M.R. High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants. J. Virol. 2007, 81:12135-12144.
19. Elena S.F., Sanjuan R. Virus evolution: insights from an experimental approach. Annu. Rev. Ecol. Evolu. Syst. 2007, 38:27-52.
20. Elena S.F., Sanjuan R., Borderia A.V., Turner P.E. Transmission bottlenecks and the evolution of fitness in rapidly evolving RNA viruses. Infect. Genet. Evol. 2001, 1:41-48.
21. Escarmis C., Lazaro E., Manrubia S.C. Population bottlenecks in quasispecies dynamics. Curr. Top. Microbiol. Immunol. 2006, 299:141-170.
22. Fabricant J. The early history of infectious bronchitis. Avian Dis. 1998, 42:648-650.
23. Frieman M., Ratia K., Johnston R.E., Mesecar A.D., Baric R.S. Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling. J. Virol. 2009, 83:6689-6705.
24. Gallardo R.A., van Santen V.L., Toro H. Host intraspatial selection of infectious bronchitis virus populations. Avian Dis. 2010, 54:807-813.
25. Gandon S., Day T. Evidences of parasite evolution after vaccination. Vaccine 2008, 26(Suppl. 3):C4-7.
26. Gandon S., Mackinnon M.J., Nee S., Read A.F. Imperfect vaccines and the evolution of pathogen virulence. Nature 2001, 414:751-756.
27. Gelb J., Wolff J.B., Moran C.A. Variant serotypes of infectious bronchitis virus isolated from commercial layer and broiler chickens. Avian Dis. 1991, 35:82-87.
28. Graham R.L., Sparks J.S., Eckerle L.D., Sims A.C., Denison M.R. SARS coronavirus replicase proteins in pathogenesis. Virus Res. 2008, 133:88-100.
29. Hagemeijer M.C., Verheije M.H., Ulasli M., Shaltiel I.A., de Vries L.A., Reggiori F., Rottier P.J., de Haan C.A. Dynamics of coronavirus replication-transcription complexes. J. Virol. 2010, 84:2134-2149.
30. Hanada K., Suzuki Y., Gojobori T. A large variation in the rates of synonymous substitution for RNA viruses and its relationship to a diversity of viral infection and transmission modes. Mol. Biol. Evol. 2004, 21:1074-1080.
31. Handel A., Bennett M.R. Surviving the bottleneck: transmission mutants and the evolution of microbial populations. Genetics 2008, 180:2193-2200.
32. Handel A., Longini I.M., Antia R. Antiviral resistance and the control of pandemic influenza: the roles of stochasticity, evolution and model details. J. Theor. Biol. 2009, 256:117-125.
33. Handel A., Rozen D.E. The impact of population size on the evolution of asexual microbes on smooth versus rugged fitness landscapes. BMC Evol. Biol. 2009, 9:236.
34. Hoelzer K., Murcia P.R., Baillie G.J., Wood J.L., Metzger S.M., Osterrieder N., Dubovi E.J., Holmes E.C., Parrish C.R. Intrahost evolutionary dynamics of canine influenza virus in naive and partially immune dogs. J. Virol. 2010, 84:5329-5335.
35. Hohdatsu T., Okada S., Koyama H. Characterization of monoclonal antibodies against feline infectious peritonitis virus type II and antigenic relationship between feline, porcine, and canine coronaviruses. Arch. Virol. 1991, 117:85-95.
36. Holmes E.C. The Evolution and Emergence of RNA Viruses 2009, Oxford University Press Inc., New York. first ed.
37. Holmes E.C., Rambaut A. Viral evolution and the emergence of SARS coronavirus. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2004, 359:1059-1065.
38. Hon C.C., Lam T.Y., Shi Z.L., Drummond A.J., Yip C.W., Zeng F., Lam P.Y., Leung F.C. Evidence of the recombinant origin of a bat severe acute respiratory syndrome (SARS)-like coronavirus and its implications on the direct ancestor of SARS coronavirus. J. Virol. 2008, 82:1819-1826.
39. Ignjatovic J., Gould G., Sapats S. Isolation of a variant infectious bronchitis virus in Australia that further illustrates diversity among emerging strains. Arch. Virol. 2006, 151:1567-1585.
40. Imbert I., Snijder E.J., Dimitrova M., Guillemot J.C., Lecine P., Canard B. The SARS-coronavirus PLnc domain of nsp3 as a replication/transcription scaffolding protein. Virus Res. 2008, 133:136-148.
41. Ivanov K.A., Thiel V., Dobbe J.C., van der Meer Y., Snijder E.J., Ziebuhr J. Multiple enzymatic activities associated with severe acute respiratory syndrome coronavirus helicase. J. Virol. 2004, 78:5619-5632.
42. Jackwood M.W., Boynton T.O., Hilt D.A., McKinley E.T., Kissinger J.C., Paterson A.H., Robertson J., Lemke C., McCall A.W., Williams S.M., Jackwood J.W., Byrd L.A. Emergence of a group 3 coronavirus through recombination. Virology 2010, 398:98-108.
43. Jackwood M.W., Hilt D.A., Lee C.-W., Kwon H.M., Callison S.A., Moore K.M., Moscoso H., Sellers H., Thayer S. Data from 11 years of molecular typing infectious bronchitis virus field isolates. Avian Dis. 2005, 49:614-618.
44. Jackwood M.W., Hilt D.A., McCall A.W., Polizzi C.N., McKinley E.T., Williams S.M. Infectious bronchitis virus field vaccination coverage and persistence of Arkansas type viruses in commercial broilers. Avian Dis. 2009, 53:175-183.
45. Johnson M.A., Jaudzems K., Wuthrich K. NMR structure of the SARS-CoV nonstructural protein 7 in solution at pH 6.5. J. Mol. Biol. 2010, 402:619-628.
46. Kenah E. Contact intervals, survival analysis of epidemic data, and estimation of R(0). Biostatistics 2011, 12:548-566.
47. Kumar P., Gunalan V., Liu B., Chow V.T., Druce J., Birch C., Catton M., Fielding B.C., Tan Y.J., Lal S.K. The nonstructural protein 8 (nsp8) of the SARS coronavirus interacts with its ORF6 accessory protein. Virology 2007, 366:293-303.
48. Lai M.M.C., Holmes K.V. Coronaviridae: the viruses and their replication. Fields Virology 2001, 1163-1185. Lippincott Williams & Wilkins, Philadelphia, PA. fourth ed. D.M. Knipe, P.M. Howley, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman, S.E. Straus (Eds.).
49. Lee C.W., Jackwood M.W. Evidence of genetic diversity generated by recombination among avian coronavirus IBV. Arch. Virol. 2000, 145:2135-2148.
50. Lee C.W., Jackwood M.W. Origin and evolution of Georgia 98 (GA98), a new serotype of avian infectious bronchitis virus. Virus Res. 2001, 80:33-39.
51. Li L., Kang H., Liu P., Makkinje N., Williamson S.T., Leibowitz J.L., Giedroc D.P. Structural lability in stem-loop 1 drives a 5' UTR-3' UTR interaction in coronavirus replication. J. Mol. Biol. 2008, 377:790-803.
52. Li W., Shi Z., Yu M., Ren W., Smith C., Epstein J.H., Wang H., Crameri G., Hu Z., Zhang H., Zhang J., McEachern J., Field H., Daszak P., Eaton B.T., Zhang S., Wang L.F. Bats are natural reservoirs of SARS-like coronaviruses. Science 2005, 310:676-679.
53. Lindner H.A., Fotouhi-Ardakani N., Lytvyn V., Lachance P., Sulea T., Menard R. The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme. J. Virol. 2005, 79:15199-15208.
54. Lipsitch M., Cohen T., Cooper B., Robins J.M., Ma S., James L., Gopalakrishna G., Chew S.K., Tan C.C., Samore M.H., Fisman D., Murray M. Transmission dynamics and control of severe acute respiratory syndrome. Science 2003, 300:1966-1970.
55. Lipsitch M., Cohen T., Murray M., Levin B.R. Antiviral resistance and the control of pandemic influenza. PLoS Med. 2007, 4:e15.
56. Lu H., Zhao Y., Zhang J., Wang Y., Li W., Zhu X., Sun S., Xu J., Ling L., Cai L., Bu D., Chen R. Date of origin of the SARS coronavirus strains. BMC Infect. Dis. 2004, 4:3.
57. Magiorkinis G., Magiorkinis E., Paraskevis D., Vandamme A.M., Van Ranst M., Moulton V., Hatzakis A. Phylogenetic analysis of the full-length SARS-CoV sequences: evidence for phylogenetic discordance in three genomic regions. J. Med. Virol. 2004, 74:369-372.
58. Manrubia S.C., Escarmis C., Domingo E., Lazaro E. High mutation rates, bottlenecks, and robustness of RNA viral quasispecies. Gene 2005, 347:273-282.
59. Manrubia S.C., Lazaro E. Viral evolution. Phys. Life Rev. 2006, 3:65-92.
60. McKinley E.T., Hilt D.A., Jackwood M.W. Avian coronavirus infectious bronchitis attenuated live vaccines undergo selection of subpopulations and mutations following vaccination. Vaccine 2008, 26:1274-1284.
61. McKinley E.T., Jackwood M.W., Hilt D.A., Kissinger J.C., Robertson J.S., Lemke C., Paterson A.H. Attenuated live vaccine usage affects accurate measures of virus diversity and mutation rates in avian coronavirus infectious bronchitis virus. Virus Res. 2011, 158:225-234.
62. Meyers L.A., Pourbohloul B., Newman M.E., Skowronski D.M., Brunham R.C. Network theory and SARS: predicting outbreak diversity. J. Theor. Biol. 2005, 232:71-81.
63. Minskaia E., Hertzig T., Gorbalenya A.E., Campanacci V., Cambillau C., Canard B., Ziebuhr J. Discovery of an RNA virus 3'→5' exoribonuclease that is critically involved in coronavirus RNA synthesis. Proc. Natl. Acad. Sci. USA 2006, 103:5108-5113.
64. Murcia P.R., Baillie G.J., Daly J., Elton D., Jervis C., Mumford J.A., Newton R., Parrish C.R., Hoelzer K., Dougan G., Parkhill J., Lennard N., Ormond D., Moule S., Whitwham A., McCauley J.W., McKinley T.J., Holmes E.C., Grenfell B.T., Wood J.L. Intra- and interhost evolutionary dynamics of equine influenza virus. J. Virol. 2010, 84:6943-6954.
65. Neuman B.W., Joseph J.S., Saikatendu K.S., Serrano P., Chatterjee A., Johnson M.A., Liao L., Klaus J.P., Yates J.R., Wuthrich K., Stevens R.C., Buchmeier M.J., Kuhn P. Proteomics analysis unravels the functional repertoire of coronavirus nonstructural protein 3. J. Virol. 2008, 82:5279-5294.
66. Novella I.S., Dutta R.N., Wilke C.O. A linear relationship between fitness and the logarithm of the critical bottleneck size in vesicular stomatitis virus populations. J. Virol. 2008, 82:12589-12590.
67. Perlman S., Gallagher T., Snijder E.J. Nidoviruses 2008, ASM Press, Washington, DC.
68. Riley S., Fraser C., Donnelly C.A., Ghani A.C., Abu-Raddad L.J., Hedley A.J., Leung G.M., Ho L.M., Lam T.H., Thach T.Q., Chau P., Chan K.P., Lo S.V., Leung P.Y., Tsang T., Ho W., Lee K.H., Lau E.M., Ferguson N.M., Anderson R.M. Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science 2003, 300:1961-1966.
69. Roberts M.G. The pluses and minuses of R0. J. R. Soc. Interface 2007, 4:949-961.
70. Ruan S. The effect of global travel on the spread of SARS. Math. Biosci. Eng. 2009, 6:207-208.
71. Snijder E.J., Bredenbeek P.J., Dobbe J.C., Thiel V., Ziebuhr J., Poon L.L., Guan Y., Rozanov M., Spaan W.J., Gorbalenya A.E. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J. Mol. Biol. 2003, 331:991-1004.
72. Song H.D., Tu C.C., Zhang G.W., Wang S.Y., Zheng K., Lei L.C., Chen Q.X., Gao Y.W., Zhou H.Q., Xiang H., Zheng H.J., Chern S.W., Cheng F., Pan C.M., Xuan H., Chen S.J., Luo H.M., Zhou D.H., Liu Y.F., He J.F., Qin P.Z., Li L.H., Ren Y.Q., Liang W.J., Yu Y.D., Anderson L., Wang M., Xu R.H., Wu X.W., Zheng H.Y., Chen J.D., Liang G., Gao Y., Liao M., Fang L., Jiang L.Y., Li H., Chen F., Di B., He L.J., Lin J.Y., Tong S., Kong X., Du L., Hao P., Tang H., Bernini A., Yu X.J., Spiga O., Guo Z.M., Pan H.Y., He W.Z., Manuguerra J.C., Fontanet A., Danchin A., Niccolai N., Li Y.X., Wu C.I., Zhao G.P. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc. Natl. Acad. Sci. USA 2005, 102:2430-2435.
73. Tangudu C., Olivares H., Netland J., Perlman S., Gallagher T. Severe acute respiratory syndrome coronavirus protein 6 accelerates murine coronavirus infections. J. Virol. 2007, 81:1220-1229.
74. Temime L., Hejblum G., Setbon M., Valleron A.J. The rising impact of mathematical modelling in epidemiology: antibiotic resistance research as a case study. Epidemiol. Infect. 2008, 136:289-298.
75. Thor S.W., Hilt D.A., Kissinger J.C., Paterson A.H., Jackwood M.W. Recombination in avian gamma-coronavirus infectious bronchitis virus. Viruses 2011, 3:1777-1799.
76. van der Goot J.A., Koch G., de Jong M.C., van Boven M. Quantification of the effect of vaccination on transmission of avian influenza (H7N7) in chickens. Proc. Natl. Acad. Sci. USA 2005, 102:18141-18146.
77. van Hemert M.J., van den Worm S.H., Knoops K., Mommaas A.M., Gorbalenya A.E., Snijder E.J. SARS-coronavirus replication/transcription complexes are membrane-protected and need a host factor for activity in vitro. PLoS Pathol. 2008, 4:e1000054.
78. van Santen V.L., Toro H. Rapid selection in chickens of subpopulations within ArkDPI-derived infectious bronchitis virus vaccines. Avian Pathol. 2008, 37:293-306.
79. Wallinga J., Teunis P. Different epidemic curves for severe acute respiratory syndrome reveal similar impacts of control measures. Am. J. Epidemiol. 2004, 160:509-516.
80. Wang X., Liao Y., Yap P.L., Png K.J., Tam J.P., Liu D.X. Inhibition of protein kinase R activation and upregulation of GADD34 expression play a synergistic role in facilitating coronavirus replication by maintaining de novo protein synthesis in virus-infected cells. J. Virol. 2009, 83:12462-12472.
81. Wodarz D., Nowak M.A. HIV therapy: managing resistance. Proc. Natl. Acad. Sci. USA 2000, 97:8193-8195.
82. Worobey M., Holmes E.C. Evolutionary aspects of recombination in RNA viruses. J. Gen. Virol. 1999, 80(Pt 10):2535-2543.
83. Yu I.T., Li Y., Wong T.W., Tam W., Chan A.T., Lee J.H., Leung D.Y., Ho T. Evidence of airborne transmission of the severe acute respiratory syndrome virus. N. Engl. J. Med. 2004, 350:1731-1739.
84. Zhai Y., Sun F., Li X., Pang H., Xu X., Bartlam M., Rao Z. Insights into SARS-CoV transcription and replication from the structure of the nsp7-nsp8 hexadecamer. Nat. Struct. Mol. Biol. 2005, 12:980-986.
85. Zhang X.W., Yap Y.L., Danchin A. Testing the hypothesis of a recombinant origin of the SARS-associated coronavirus. Arch. Virol. 2004, 150:1-20.
86. Ziebuhr J. The coronavirus replicase. Curr. Top. Microbiol. Immunol. 2005, 287:57-94.
87. Ziebuhr J. The coronavirus replicase: insights into a sophisticated enzyme machinery. Adv. Exp. Med. Biol. 2006, 581:3-11.
88. Ziebuhr J., Schelle B., Karl N., Minskaia E., Bayer S., Siddell S.G., Gorbalenya A.E., Thiel V. Human coronavirus 229E papain-like proteases have overlapping specificities but distinct functions in viral replication. J. Virol. 2007, 81:3922-3932.